Literature DB >> 18448430

The structure and interactions of the proline-rich domain of ASPP2.

Shahar Rotem1, Chen Katz, Hadar Benyamini, Mario Lebendiker, Dmitry Veprintsev, Stefan Rüdiger, Tsafi Danieli, Assaf Friedler.   

Abstract

ASPP2 is a pro-apoptotic protein that stimulates the p53-mediated apoptotic response. The C terminus of ASPP2 contains ankyrin (Ank) repeats and a SH3 domain, which mediate its interactions with numerous partner proteins such as p53, NFkappaB, and Bcl-2. It also contains a proline-rich domain (ASPP2 Pro), whose structure and function are unclear. Here we used biophysical and biochemical methods to study the structure and the interactions of ASPP2 Pro, to gain insight into its biological role. We show, using biophysical and computational methods, that the ASPP2 Pro domain is natively unfolded. We found that the ASPP2 Pro domain interacts with the ASPP2 Ank-SH3 domains, and mapped the interaction sites in both domains. Using a combination of peptide array screening, biophysical and biochemical techniques, we found that ASPP2 Ank-SH3, but not ASPP2 Pro, mediates interactions of ASPP2 with peptides derived from its partner proteins. ASPP2 Pro-Ank-SH3 bound a peptide derived from its partner protein NFkappaB weaker than ASPP2 Ank-SH3 bound this peptide. This suggested that the presence of the proline-rich domain inhibited the interactions mediated by the Ank-SH3 domains. Furthermore, a peptide from ASPP2 Pro competed with a peptide derived from NFkappaB on binding to ASPP2 Ank-SH3. Based on our results, we propose a model in which the interaction between the ASPP2 domains regulates the intermolecular interactions of ASPP2 with its partner proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448430     DOI: 10.1074/jbc.M708717200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2.

Authors:  Chen Katz; Hadar Benyamini; Shahar Rotem; Mario Lebendiker; Tsafi Danieli; Anat Iosub; Hadar Refaely; Monica Dines; Vered Bronner; Tsafrir Bravman; Deborah E Shalev; Stefan Rüdiger; Assaf Friedler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

2.  Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms.

Authors:  Koen Schipper; Anne Paulien Drenth; Eline van der Burg; Samuel Cornelissen; Sjoerd Klarenbeek; Micha Nethe; Jos Jonkers
Journal:  Cancer Res       Date:  2020-02-14       Impact factor: 12.701

3.  N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence.

Authors:  Zhiping Wang; Yuangang Liu; Maho Takahashi; Kathryn Van Hook; Kerstin M Kampa-Schittenhelm; Brett C Sheppard; Rosalie C Sears; Philip J S Stork; Charles D Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

4.  ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.

Authors:  Kathryn Van Hook; Zhiping Wang; Dexi Chen; Casey Nold; Zhiyi Zhu; Pavana Anur; Hun-Joo Lee; Zhiyong Yu; Brett Sheppard; Mu-Shui Dai; Rosalie Sears; Paul Spellman; Charles D Lopez
Journal:  Biochem Biophys Res Commun       Date:  2016-12-08       Impact factor: 3.575

5.  Integrated strategy reveals the protein interface between cancer targets Bcl-2 and NAF-1.

Authors:  Sagi Tamir; Shahar Rotem-Bamberger; Chen Katz; Faruck Morcos; Kendra L Hailey; John A Zuris; Charles Wang; Andrea R Conlan; Colin H Lipper; Mark L Paddock; Ron Mittler; José N Onuchic; Patricia A Jennings; Assaf Friedler; Rachel Nechushtai
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-25       Impact factor: 11.205

Review 6.  The selective BH4-domain biology of Bcl-2-family members: IP3Rs and beyond.

Authors:  Giovanni Monaco; Tim Vervliet; Haidar Akl; Geert Bultynck
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

7.  Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma.

Authors:  Sjors M Kas; Julian R de Ruiter; Koen Schipper; Stefano Annunziato; Eva Schut; Sjoerd Klarenbeek; Anne Paulien Drenth; Eline van der Burg; Christiaan Klijn; Jelle J Ten Hoeve; David J Adams; Marco J Koudijs; Jelle Wesseling; Micha Nethe; Lodewyk F A Wessels; Jos Jonkers
Journal:  Nat Genet       Date:  2017-06-26       Impact factor: 38.330

8.  The C terminus of p53 binds the N-terminal domain of MDM2.

Authors:  Masha V Poyurovsky; Chen Katz; Oleg Laptenko; Rachel Beckerman; Maria Lokshin; Jinwoo Ahn; In-Ja L Byeon; Ronen Gabizon; Melissa Mattia; Andrew Zupnick; Lewis M Brown; Assaf Friedler; Carol Prives
Journal:  Nat Struct Mol Biol       Date:  2010-07-18       Impact factor: 15.369

Review 9.  Messing up disorder: how do missense mutations in the tumor suppressor protein APC lead to cancer?

Authors:  David P Minde; Zeinab Anvarian; Stefan Gd Rüdiger; Madelon M Maurice
Journal:  Mol Cancer       Date:  2011-08-22       Impact factor: 27.401

10.  Regulation of ASPP2 interaction with p53 core domain by an intramolecular autoinhibitory mechanism.

Authors:  Shahar Rotem-Bamberger; Chen Katz; Assaf Friedler
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.